| Dawn Domingue Landry, RPH | |
|
1223 N Victor Ii Blvd, Morgan City, LA 70380-1327 | |
| (985) 385-2794 | |
| (985) 702-1593 |
| Full Name | Dawn Domingue Landry |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1223 N Victor Ii Blvd, Morgan City, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013215144 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 14140 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dawn Domingue Landry, RPH 1223 N Victor Ii Blvd, Morgan City, LA 70380-1327 Ph: (985) 385-2794 | Dawn Domingue Landry, RPH 1223 N Victor Ii Blvd, Morgan City, LA 70380-1327 Ph: (985) 385-2794 |
News Archive
NCCNHR (formerly the National Citizens' Coalition for Nursing Home Reform) announced today the launch of a major strategic planning process which will help strengthen the organization's role as a voice for individuals receiving long-term care.
Johnson & Johnson Medical Devices Companies today announced that Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of heart arrhythmias, enrolled the first patient in the WaveCrest Investigational Device Exemption Trial.
SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based biomarker testing, today announced that it intends to raise gross proceeds of up to CDN $5 million through a non-brokered private placement of up to 2,000,000 units of the Company at a price of $2.50 per unit.
Millions of people around the world use acid suppressants called proton pump inhibitors for conditions like heartburn, gastritis and stomach ulcers. Researchers at Karolinska Institutet in Sweden now report that how the long-term use of these drugs could increase the risk of developing dementia.
A team led by Massachusetts Eye and Ear researchers has identified a novel therapeutic target for retinal neovascularization, or abnormal blood vessel growth in the retina, a hallmark of advanced diabetic eye disease (proliferative diabetic retinopathy).
› Verified 4 days ago
Dudley Pellegrin Jr., Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 973 Highway 90 E, Morgan City, LA 70380 Phone: 985-395-9625 | |
Mr. Louis Michael Spitale, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1200 N Victor Ii Blvd, Morgan City, LA 70380 Phone: 985-255-4789 Fax: 985-255-4788 | |
Dawn Guillot, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 815 Brashear Ave, Morgan City, LA 70380 Phone: 985-384-3302 | |
Dr. Latasha Tomeka Wise, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 815 Brashear Ave, Morgan City, LA 70380 Phone: 985-384-3302 | |
Dr. Arielle Collins, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 815 Brashear Ave, Morgan City, LA 70380 Phone: 504-912-5117 | |
Donald B Olivier, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6502 Highway 182 E, Morgan City, LA 70380 Phone: 985-384-2126 Fax: 985-384-2120 |